Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueTax ProvisionsTax Rate
Others
Ratios

Acadia Healthcare Company (ACHC) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Acadia Healthcare Company (ACHC) over the last 16 years, with Q3 2025 value amounting to $128.8 million.

  • Acadia Healthcare Company's Cost of Revenue rose 1484.79% to $128.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $495.1 million, marking a year-over-year increase of 1759.66%. This contributed to the annual value of $440.8 million for FY2024, which is 1334.05% up from last year.
  • As of Q3 2025, Acadia Healthcare Company's Cost of Revenue stood at $128.8 million, which was up 1484.79% from $134.4 million recorded in Q2 2025.
  • Acadia Healthcare Company's 5-year Cost of Revenue high stood at $134.4 million for Q2 2025, and its period low was $72.0 million during Q1 2021.
  • Its 5-year average for Cost of Revenue is $97.8 million, with a median of $95.9 million in 2023.
  • As far as peak fluctuations go, Acadia Healthcare Company's Cost of Revenue skyrocketed by 3238.47% in 2021, and later skyrocketed by 445.69% in 2023.
  • Quarter analysis of 5 years shows Acadia Healthcare Company's Cost of Revenue stood at $79.1 million in 2021, then increased by 18.77% to $93.9 million in 2022, then rose by 4.46% to $98.1 million in 2023, then grew by 20.16% to $117.9 million in 2024, then grew by 9.25% to $128.8 million in 2025.
  • Its Cost of Revenue was $128.8 million in Q3 2025, compared to $134.4 million in Q2 2025 and $114.0 million in Q1 2025.